Curbstone Financial Management Corp’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
16,532
+800
+5% +$71.4K 0.29% 76
2026
Q1
$1.13M Hold
15,732
0.22% 100
2025
Q4
$1.25M Buy
15,732
+900
+6% +$71K 0.24% 88
2025
Q3
$1.12M Sell
14,832
-646
-4% -$44.3K 0.22% 103
2025
Q2
$1.07M Sell
15,478
-1,250
-7% -$82K 0.22% 104
2025
Q1
$1.13M Sell
16,728
-1,718
-9% -$103K 0.24% 98
2024
Q4
$828K Sell
18,446
-1,518
-8% -$85.2K 0.18% 118
2024
Q3
$1.26M Sell
19,964
-4,248
-18% -$248K 0.27% 91
2024
Q2
$1.43M Sell
24,212
-1,924
-7% -$120K 0.31% 82
2024
Q1
$2.08M Sell
26,136
-750
-3% -$57.3K 0.45% 58
2023
Q4
$2.12M Sell
26,886
-100
-0.4% -$7.12K 0.48% 56
2023
Q3
$1.88M Sell
26,986
-150
-0.6% -$10.6K 0.47% 60
2023
Q2
$1.88M Buy
27,136
+750
+3% +$53.4K 0.45% 63
2023
Q1
$1.96M Sell
26,386
-1,376
-5% -$115K 0.48% 59
2022
Q4
$2.59M Sell
27,762
-750
-3% -$72.4K 0.65% 44
2022
Q3
$2.72M Sell
28,512
-4
-0% -$396 0.68% 39
2022
Q2
$2.64M Sell
28,516
-4,450
-13% -$434K 0.61% 47
2022
Q1
$3.34M Sell
32,966
-1,670
-5% -$175K 0.62% 46
2021
Q4
$3.57M Sell
34,636
-50
-0.1% -$4.62K 0.63% 46
2021
Q3
$2.94M Sell
34,686
-150
-0.4% -$12.6K 0.55% 50
2021
Q2
$2.91M Sell
34,836
-200
-0.6% -$16.4K 0.55% 51
2021
Q1
$2.64M Sell
35,036
-1,250
-3% -$91.1K 0.53% 54
2020
Q4
$2.48M Buy
36,286
+618
+2% +$40.2K 0.52% 54
2020
Q3
$2.08M Buy
35,668
+910
+3% +$56.6K 0.5% 55
2020
Q2
$2.26M Buy
34,758
+1,250
+4% +$78.7K 0.58% 49
2020
Q1
$1.99M Sell
33,508
-2,620
-7% -$175K 0.6% 47
2019
Q4
$2.68M Sell
36,128
-190
-0.5% -$13.3K 0.64% 45
2019
Q3
$2.29M Sell
36,318
-138
-0.4% -$8.18K 0.59% 48
2019
Q2
$1.99M Buy
36,456
+11,616
+47% +$626K 0.52% 54
2019
Q1
$1.34M Buy
24,840
+3,150
+15% +$194K 0.36% 75
2018
Q4
$1.42M Buy
21,690
+6,720
+45% +$502K 0.43% 66
2018
Q3
$1.18M Buy
14,970
+780
+5% +$55.8K 0.31% 90
2018
Q2
$913K Sell
14,190
-120
-0.8% -$7.91K 0.25% 107
2018
Q1
$890K Buy
14,310
+7,060
+97% +$507K 0.25% 108
2017
Q4
$526K Sell
7,250
-14,980
-67% -$1.09M 0.29% 97
2017
Q3
$1.81M Buy
22,230
+11,807
+113% +$934K 0.52% 62
2017
Q2
$839K Sell
10,423
-70
-0.7% -$5.53K 0.5% 61
2017
Q1
$824K Sell
10,493
-30
-0.3% -$2.4K 0.51% 61
2016
Q4
$830K Sell
10,523
-10,463
-50% -$847K 0.52% 57
2016
Q3
$1.87M Buy
20,986
+242
+1% +$22.8K 0.6% 48
2016
Q2
$1.99M Buy
20,744
+200
+1% +$19.9K 0.67% 43
2016
Q1
$2.13M Sell
20,544
-650
-3% -$63.2K 0.72% 38
2015
Q4
$2.07M Buy
21,194
+11,477
+118% +$1.12M 0.71% 36
2015
Q3
$937K Sell
9,717
-107
-1% -$11.2K 0.68% 39
2015
Q2
$1.03M Buy
9,824
+1,615
+20% +$165K 0.69% 42
2015
Q1
$847K Buy
8,209
+3,737
+84% +$378K 0.57% 49
2014
Q4
$431K Buy
4,472
+1,120
+33% +$98.7K 0.33% 85
2014
Q3
$267K Sell
3,352
-150
-4% -$11.8K 0.21% 110
2014
Q2
$264K Sell
3,502
-25
-0.7% -$1.89K 0.2% 111
2014
Q1
$264K Buy
+3,527
New +$249K 0.22% 107

Other funds holding CVS

Curbstone Financial Management Corp's CVS Position: Q2 2026 in Review

Curbstone Financial Management Corp increased its CVS Health (CVS) stake by 5.1% in Q2 2026, buying an estimated $71.4K and bringing the position to 16,532 shares worth $1.71M. The position accounts for 0.29% of the portfolio, ranked #76.

Curbstone Financial Management Corp first reported a position in CVS in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.57M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Curbstone Financial Management Corp held 16,532 shares of CVS Health worth $1.71M as of Q2 2026.
  • Curbstone Financial Management Corp bought 800 CVS Health shares in Q2 2026, an estimated $71.4K.
  • CVS Health made up 0.29% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #76 holding.
  • Curbstone Financial Management Corp first reported a position in CVS Health in Q1 2014 and has held it in 50 quarters since.
  • Curbstone Financial Management Corp's CVS Health position peaked at $3.57M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.